Verastem, Inc. (VSTM)
NASDAQ: VSTM · IEX Real-Time Price · USD
3.320
+0.030 (0.91%)
At close: Jul 19, 2024, 4:00 PM
3.340
+0.020 (0.60%)
Pre-market: Jul 22, 2024, 8:37 AM EDT
Verastem Employees
Verastem had 73 employees as of December 31, 2023. The number of employees increased by 16 or 28.07% compared to the previous year.
Employees
73
Change (1Y)
16
Growth (1Y)
28.07%
Revenue / Employee
n/a
Profits / Employee
-$1,445,425
Market Cap
84.08M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sangamo Therapeutics | 405 |
| CASI Pharmaceuticals | 176 |
| Hyperfine | 131 |
| AlloVir | 112 |
| BioAtla | 65 |
| AN2 Therapeutics | 41 |
| Clearside Biomedical | 30 |
| Benitec Biopharma | 18 |
VSTM News
- 7 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verastem, Inc. - VSTM - Accesswire
- 10 days ago - Verastem Oncology Announces First Patient Dosed with GFH375/VS-7375, a KRAS G12D (ON/OFF) Inhibitor, in a Phase 1/2 Trial in China as Part of Collaboration with GenFleet Therapeutics - Business Wire
- 11 days ago - Verastem, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 14 days ago - Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 14 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verastem, Inc. - VSTM - GlobeNewsWire
- 16 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Verastem, Inc. - VSTM - Accesswire
- 21 days ago - Verastem Oncology Announces Addition to Russell 3000® and Russell Microcap® Indexes - Business Wire
- 21 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Verastem, Inc. – VSTM - GlobeNewsWire